Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy and gynecological acceptance of the product in postmenopausal vaginal atrophy or urinary incontinence
RBR-8dzth2Completed
- Sponsor
- Medcin Instituto da Pele
- Start
- Jul 2017
- Countries
- 1
01
Overview
Open-label trial in atrophic vaginitis and urinary incontinence (UI) (2 cohorts), sponsored by Medcin Instituto da Pele. Primary endpoints: Clinical efficacy after product use and Gynecological acceptance. Started Jul 2017; status: completed.
02
Conditions
atrophic vaginitisurinary incontinence (UI)
Beyond the preview
Go deeper on RBR-8dzth2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8dzth2.